Ropivacaine inhibits the malignant behavior of lung cancer cells by regulating retinoblastoma-binding protein 4
Background Ropivacaine is a local anesthetic commonly used in regional nerve blocks to manage perioperative pain during lung cancer surgery. Recently, the antitumor potential of ropivacaine has received considerable attention. Our previous study showed that ropivacaine treatment inhibits the maligna...
Main Authors: | Weiai Jia, Junmei Shen, Sisi Wei, Chao Li, Jingpu Shi, Lianmei Zhao, Huiqun Jia |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2023-11-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/16471.pdf |
Similar Items
-
Ropivacaine Inhibits Lung Cancer Cell Malignancy Through Downregulation of Cellular Signaling Including HIF-1α In Vitro
by: Junmei Shen, et al.
Published: (2022-02-01) -
Retinoblastoma Binding Protein 4 Modulates Temozolomide Sensitivity in Glioblastoma by Regulating DNA Repair Proteins
by: Gaspar J. Kitange, et al.
Published: (2016-03-01) -
Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
by: Miguel Santos, et al.
Published: (2021-11-01) -
Overlapping functions of RBBP4 and RBBP7 in regulating cell proliferation and histone H3.3 deposition during mouse preimplantation development
by: Lieying Xiao, et al.
Published: (2022-10-01) -
Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research
by: Lize Cai, et al.
Published: (2023-11-01)